Search Results
Oct 21, 2025, 08:39 ET Parents Ditch Candy for Crunch: Crispy Fruit™ by Crispy Green® Leads the Healthy Halloween Snack Trend
You'll Treasure. Where to Find Crispy Fruit ™ Find Crispy Fruit™ in the produce section of grocery and natural food stores,
More news about: Crispy Green
Oct 21, 2025, 07:58 ET Trust & Will® Names Jackie Frommer Chief Commercial Officer to Drive Enterprise Growth and Financial Services Expansion
financial wellness. Recognized for innovation and leadership, we have earned spots on the CNBC Disruptor 50, Inc. 5000, and Deloitte Technology Fast 500™ lists. Learn more at
More news about: Trust & Will
Oct 21, 2025, 07:30 ET Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
ROSA® Knee with OptimiZe ™: the newest version of the ROSA® Knee System that customizes and looks to enhance the surgeon's experience with personalized and intelligent
More news about: Zimmer Biomet Holdings, Inc.
Oct 21, 2025, 05:00 ET Baby Safety Alliance Reveals 2025 Awards of Excellence Winners
Rotating Convertible Car Seat Design/Fashion/StyleEvenflo® Shyft Intuiti+™ Travel System Featuring Revolve180™ LiteMax NXT with SensorySoothe™ with Green & Gentle Feeding/Bathing/ChangingMunchkin
More news about: Baby Safety Alliance
Oct 20, 2025, 16:05 ET DuPont Schedules Third Quarter 2025 Earnings Conference Call
investors.dupont.com. DuPontTM and all products, unless otherwise noted, denoted with TM, SMor ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.
More news about: DuPont
Oct 20, 2025, 11:14 ET Meet the Future of Home Hydration with the Elkay®™ Liv EZ
More news about: Zurn Elkay Water Solutions
Oct 20, 2025, 09:00 ET Aperia Launches Nearby Issues Feature to Boost Technician Efficiency
user-friendly line-up of tire management solutions available to commercial fleets worldwide, including Halo® Tire Inflator, Halo Connect®, and Halo Connect i3™. For more information, visit AperiaTech.com. Media Contact:Aperia TechnologiesAperia Press Relations
More news about: Aperia Technologies
Oct 20, 2025, 09:00 ET League's Fall 2025 Release Unveils League Agent Teams™ to Deliver 24/7 Hyper-Personalized Healthcare
every member, caregiver, and AI agent. League AI's differentiated approach is built on four key pillars: League Agent Teams ™ : A powerful multi-agent system, including a suite of AI agents that are purpose-built to execute healthcare-specific actions with precision,
More news about: League Inc.
Oct 20, 2025, 08:45 ET Global Defense Stocks Have Rocketed Higher In 2025 as Artificial Intelligence Technology Fueling Big Gains
announced a development roadmap with AeroVironment, Inc. (NASDAQ: AVAV) to enable Red Cat's FANG™ FPV drones to be deployed as a payload from AV's P550™ all-electric Group 2 eVTOL UAS. Red Cat is actively working with AV to develop a marsupial configuration that enables the P550
More news about: MarketNewsUpdates
Oct 20, 2025, 07:00 ET CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
strong, animal-free alternative for tissue engineering, regenerative medicine, and drug discovery applications." About Collink.3D ™ Collink.3D™ is a recombinant human type I collagen methacrylamide bioink, produced using genetically engineered plants and free of any animal-derived
More news about: CollPlant
Oct 20, 2025, 06:00 ET GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
10.1016/j.annonc.2021.05.806 GRAIL, Inc. False positive rate. [Data on file: GR-2025-0256] Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:
More news about: GRAIL, Inc.
Oct 20, 2025, 05:40 ET Hisense MEA Marks Real Madrid Partnership with Exciting Retail Promotions and Regional Gaming Competition
total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2024). As the official sponsor of the FIFA World Cup 2026™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide. With 31 R&D centres, 36 industrial
More news about: Hisense Middle East
Oct 20, 2025, 05:36 ET Hisense MEA Marks Real Madrid Partnership with Exciting Retail Promotions and Regional Gaming Competition
total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2024). As the official sponsor of the FIFA World Cup 2026™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide. With 31 R&D centres, 36 industrial
More news about: Hisense Middle East
Oct 19, 2025, 19:30 ET IZERVAY™ (avacincaptad pegol intravitreal solution) Showed Increased Benefit in Reducing Geographic Atrophy Progression Over Time and Consistent Long-Term Safety
authorities around the world to bring ACP to GA patients globally. About IZERVAY ™ (avacincaptad pegol intravitreal solution) INDICATION AND IMPORTANT
More news about: Astellas Pharma Inc.
Oct 19, 2025, 10:30 ET Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
7 Wise-Draper TM, Bahig H, Tonneau M, Karivedu V, Burtness B. Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges. American
More news about: Johnson & Johnson
Oct 18, 2025, 05:03 ET GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
10.1016/j.annonc.2021.05.806 GRAIL, Inc. False positive rate. [Data on file: GR-2025-0256] Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:
More news about: GRAIL, Inc.
Oct 17, 2025, 16:00 ET FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
dysfunction to the pathogenesis of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33:782–790. Laidlaw TM, et al. Chronic Rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 2021;9:1133–1141. Liao B, et al.
More news about: Amgen
Oct 17, 2025, 08:00 ET Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not
More news about: Eli Lilly and Company
Oct 17, 2025, 05:48 ET 넥스티어, 2025 오토테크 브레이크스루 어워드에서 "올해의 자동차 소프트웨어 솔루션" 부문 수상
MotionIQ/Control ™ : 스티어-바이-브레이크, 핸즈-오프 감지, Quiet Wheel™ 스티어링, 노면 상태 감지 등 최첨단 자동차 동역학 기능을 비롯한 기타 기능으로 더욱 안전하고 특별한 주행 경험을 제공한다. MotionIQ/Dev ™ : 최첨단 소프트웨어 개발 도구가 자동 코딩 및 통합을 통해 기능 개발에 걸리는 시간을 일 단위에서 분 단위로 앞당긴다.
More news about: Nexteer Automotive
Oct 16, 2025, 19:24 ET NORDIC GROUP B.V. COMPARTE DATOS DEL GEL CANALICULAR LACRIFILL®
https://mma.prnewswire.com/media/2630120/Nordic_Pharma_TM_Logo_RGB__1_Logo.jpg
More news about: Nordic Pharma
Oct 16, 2025, 18:33 ET Phoenix Tower International gana la certificación 2025 Great Place To Work® en 14 mercados
aquellos que impulsan su crecimiento, innovación y propósito todos los días. La certificación Great Place To Work ®™ es un prestigioso premio que se basa por completo en lo que los empleados dicen sobre su experiencia en el trabajo. El reconocimiento es ampliamente
More news about: Phoenix Tower International
Oct 16, 2025, 16:43 ET DIE NORDIC GROUP B.V. WIRD ÜBER IHRE TOCHTERGESELLSCHAFT NORDIC PHARMA, INC. (USA) IM RAHMEN DER AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025 PATIENTENDATEN UND ERFAHRUNGSBERICHTE ZU LACRIFILL® CANALICULAR GEL, EINER NEUARTIGEN THERAPIE FÜR TROCKENE AUGEN, VERÖFFENTLICHEN
https://mma.prnewswire.com/media/2630120/Nordic_Pharma_TM_Logo_RGB__1_Logo.jpg
More news about: Nordic Pharma
Oct 16, 2025, 16:41 ET NORDIC GROUP B.V., PAR L'INTERMÉDIAIRE DE SA FILIALE NORDIC PHARMA, INC. (U.S.), PARTAGERA DES DONNÉES PATIENTS ET UNE ÉTUDE SUR L'EXPÉRIENCE DES PATIENTS AVEC LE GEL CANALICULAIRE LACRIFILL®, UN NOUVEAU TRAITEMENT POUR LA SÉCHERESSE OCULAIRE, PENDANT LA CONFÉRENCE 2025 DE L'ACADÉMIE AMÉRICAINE D'OPHTHALMOLOGIE (AAO)
https://mma.prnewswire.com/media/2630120/Nordic_Pharma_TM_Logo_RGB__1_Logo.jpg
More news about: Nordic Pharma
Oct 16, 2025, 15:45 ET Luxor® Workspaces Debuts Healthcare Line with Research-Driven Collection of Medical Workstations
New Vitalize ™ and VitalPower™ Healthcare Rolling Medical Carts Deliver Mobility, Cleanability, and Ergonomic Comfort Backed by Insights from Real-World Care Teams WAUKEGAN, Ill., Oct.
More news about: Luxor Workspaces
Oct 16, 2025, 10:00 ET Lilly confirms date and conference call for third-quarter 2025 financial results announcement
the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not
More news about: Eli Lilly and Company